Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
ICA-105665 is a novel small molecule compound for the treatment of epilepsy. It is a novel opener of the KCNQ ion channel which in preclinical studies has demonstrated a broad... In addition, ICA-105665 has also demonstrated activity in certain models of neuropathic pain.
- Mechanism
- Curator reviewed
ICA-105665 is an activator of subtypes of KCNQ ion channels, which are attractive targets for the treatment of epilepsy based on their function and genetic linkage to a seizure disorder.
- Primary indication
- Investigated for use/treatment in epilepsy.Curator reviewed
- Code names
- ICA-105665
Resolves to
What you can answer from here — as of April 02, 2025
Which drugs share a target with ICA-105665, and which of those have an active Phase 3 trial?